Brainify.AI is a legitimate, high-potential deep tech startup specializing in AI-driven EEG biomarkers for precision psychiatry, specifically improving antidepressant clinical trial success. Despite the low-quality submission (likely a test or hasty entry), verified external data confirms significant traction, including $2M in seed funding (Sept 2024), acceptance into the Merck Digital Sciences Studio, and partnerships with HIVE BIO. The project addresses a critical, high-value problem in pharmaceutical R&D. The score reflects strong technical innovation and verified business traction, adjusted for the specific niche reach and poor submission quality.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline